Patents by Inventor Matthew Tsn-Wei CHANG

Matthew Tsn-Wei CHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BELVARAFENIB FOR USE IN CANCER TREATMENT
    Publication number: 20230233567
    Abstract: Provided are methods for the use of belvarafenib to treat cancer having at least one mutation selected from a BRAFV600E mutation, a KRASG12V mutation, a KRASG12D mutation, a KRASG12C mutation, a KRASG12R mutation, a KRASG13D mutation, a KRASQ61H mutation, a NRASG12D mutation, a NRASG13D mutation, a NRASQ61K mutation, a NRASQ61L mutation, a NRASQ61R mutation, and a NRASG12C mutation.
    Type: Application
    Filed: May 17, 2021
    Publication date: July 27, 2023
    Inventors: Tae Won KIM, Yoon-hee HONG, Young Su NOH, Matthew Tsn-Wei CHANG, Shiva MALEK, Yibing YAN, Ivana Yen Yen YEN
  • SYSTEMS AND METHODS TO TRACK THE EVOLUTION OF SINGLE CELLS
    Publication number: 20230122540
    Abstract: Cells in a given population often display heterogeneity that may affect how each cell responds to a particular treatment or growth condition. The methods described herein allow determination of which cells from an initial population survive a treatment or condition, and how surviving cells evolve over time. For example, the methods described herein may be used to model drug resistance, response and/or adaptation in a cell population.
    Type: Application
    Filed: September 16, 2022
    Publication date: April 20, 2023
    Inventors: Xin YE, Matthew Tsn-Wei CHANG